Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABX-CBL vs Atgam in Steroid-Resistant Acute GVHD
NCT00035880Phase 3Completed
- Sponsor
- Abgenix
- Start
- Oct 1999
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of gavilimomab in Acute Graft-Versus-Host Disease (aGvHD), sponsored by Abgenix. Started Oct 1999; status: completed.
02
Drugs
gavilimomab
03
Conditions
Acute Graft-Versus-Host Disease (aGvHD)
Beyond the preview
Go deeper on NCT00035880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00035880.